Light therapy study for dry age-related macular degeneration
Part of Eyes & vision clinical trials.
This study tests a light-based treatment (photobiomodulation) for dry AMD, using the Valeda Light Delivery System. It may help improve vision and eye health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with dry age-related macular degeneration (dry AMD) by your eye doctor.
- You are able to understand and follow study instructions and have signed a consent form.
- You do not have or have ever had the 'wet' form of AMD or other eye conditions with fluid buildup.
- You are not using any medications or products that make your skin or eyes sensitive to light (like certain creams or injections) within 30 days before treatment, unless your doctor says it's okay.
- You are not sensitive to yellow, red, or near-infrared light, and have no history of light-triggered conditions like seizures or migraines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a vision treatment approach for people age 50+ who have dry age-related macular degeneration (AMD) and are legally blind from it. It aims to see whether the treatment can improve vision-related outcomes in the study eye.
This study tests a device that uses gentle electrical stimulation to try to improve vision in people with early to intermediate dry age-related macular degeneration. It could help slow vision loss and improve daily function.
This early-stage study tests whether a stem-cell–derived transplant to the back of the eye is safe and tolerable in people with dry age-related macular degeneration (AMD). If you qualify, you may receive the transplant and have close follow-up to watch for side effects.
This study observes how dry age-related macular degeneration (AMD) changes over time using regular eye exams. It may help doctors better understand the natural pattern of progression and which patients are more likely to worsen.
This trial studies whether a light-based treatment (photobiomodulation) can help people with dry age-related macular degeneration in one eye. Because one eye is treated while the other eye has a different type of AMD in the study design, eligibility depends on which type of AMD you have in each eye.
This trial tests whether a special light treatment (photobiomodulation) can help people with dry age-related macular degeneration (AMD). It is designed for those with early to moderate dry AMD who still have fairly good vision.
Hear when a new Dry Age-related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.